Interleukin-11. Biological activity and clinical studies

BioDrugs

Volumn 8, Issue 6, 1997, Pages 418-429

  Dorner, Andrew J ^a   Goldman, Samuel J ^a   Keith Jr , James C ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; HEME OXYGENASE; INTERLEUKIN 11; RECOMBINANT INTERLEUKIN 11; TISSUE INHIBITOR OF METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TYPE; CROHN DISEASE; DOG; ENDOTOXEMIA; ENTERITIS; ESCHERICHIA COLI; GENE EXPRESSION; GUINEA PIG; HAMSTER; HUMAN; IN VITRO STUDY; LIVER CELL; MEGAKARYOPOIESIS; MOLECULAR CLONING; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; STEM CELL; STOMACH MUCOSA LESION; SYNOVIOCYTE; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS;

EID: 0030699366     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199708060-00002     Document Type: Review

References (64)

1. Turner KJ, Clark SC. Interleukin-11: biological and clinical perspectives. In: Mertelsmann R, Herrmann F, editors. Hematopoietic growth factors in clinical applications. New York: Marcel Dekker, 1995: 315-6
2. Du XX, Williams DA. Interleukin-11: a multifunctional growth factor derived from the hematopoietic microenvironment. Blood 1994; 83: 2023-30
3. Trepicchio WL, Bozza M, Pednault G, et al. Recombinant human interleukin-11 attenuates the inflammatory response through downregulation of proinflammatory cytokine release and nitric oxide production. J Immunol 1996; 157: 3627-34
4. Paul SR, Bennett F, Calvetti JA, et al. Molecular cloning of a cDNA encoding interleukin-11, a stromal cell-derived lymphopoietic and hematopoietic cytokine. Proc Natl Acad Sci USA 1990; 87: 7512-6
5. McKinley D, Wu Q, Yang-Feng T, et al. Genomic sequence and chromosomal location of human interleukin-11 gene (IL-11). Genomics 1992; 13: 814-9
6. Elias JA, Zheng T, Einarsson O. Epithelial interleukin-11: regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem 1994; 269: 22261-8
7. Einarsson O, Geba P, Zhu Z, et al. Interleukin-11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J Clin Invest 1996; 97: 915-24
8. Elias JA, Zheng T, Whiting NL, IL-1 and transforming growth factor-β regulation of fibroblast-derived IL-11. J Immunol 1994; 152: 2421-9
9. Zheng T, Nathanson MH, Elias JA. Histamine augments cytokine-stimulated IL-11 production by human lung fibroblasts. J Immunol 1994; 153: 4742-52
10. Maier R, Ganu V, Lotz M. Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem 1993; 268: 21527-32
11. Suen Y, Chang M, Min Lee S, et al. Regulation of interleukin-11 protein and mRNA expression in neonatal and adult fibroblasts and endothelial cells. Blood 1994; 84: 4125-34
12. Elias JA, Tang W, Horowitz MC, Cytokine and hormonal stimulation of human osteosarcoma interleukin-11 production. Endocrinology 1995; 136: 489-98
13. Chang M, Suen Y, Meng G, et al. Differential mechanisms in the regulation of endogenous levels of thrombopoietin and interleukin-11 during thrombocytopenia: insight into the regulation of platelet production. Blood 1996; 88: 3354-62
14. Du X, Everett ET, Wang G, et al. Murine interleukin-11 (IL-11) is expressed at high levels in the hippocampus and expression is developmentally regulated in the lestis. J Cell Physiol 1996; 168: 362-72
15. Davidson AJ, Freeman S-A, Crosier KE. Expression of murine interleukin-11 and its receptor α-chain in adult and embryonic tissues. Stem Cells 1997; 15(2): 119-124
16. Taga T, Yoshida K, Hirota H, et al. Physiological and pathological role of gp130, a common signal transducer for IL-6 family of cytokines. In: Kehara SI, Takaku F, Good RA, editors. Bone marrow transplant: basic and clinical studies. Tokyo: Springer-Verlag, 1996: 101-9
17. Stahl N, Boulton TG, Farruggella T, et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 β-receptor components. Science 1994; 263: 92-5
18. Narazaki M, Witthuhn BA, Yoshida K, et al. Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 1994; 91: 2285-9
19. Yin T, Yang Y-C. Mitogen-activated protein kinases and ribosomal S6 protein kinases are involved in signalling pathways shared by interleukin-11, interleukin-6, leukemia inhibitory factor, and oncostatin M in mouse 3T3-L1 cells. J Biol Chem 1994; 269: 3731-8
20. Boulton TG, Stahl N, Yancopoulos GD. Ciliary neutrotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J Biol Chem 1994; 269: 11648-55
21. Wegenka UM, Lutticken C, Buchmann J, et al. The interleukin-6-activated acute-phase response factor is antigenically and functionally related to members of the signal transduce and activator of transcription (STAT) family. Mol Cell Biol 1994; 14: 3186-96
22. Hilton DJ, Hilton AA, Raicevic A, et al. Cloning of a murine IL-11 receptor α-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J 1994; 13: 4765-75
23. Neuhaus H, Bettenhausen B, Bilinski P, et al. Et12, a novel putative type-1 cytokine receptor expressed during mouse embryogenesis at high levels in skin and cells with skeletogenic potential. Dev Biol 1994; 166: 531-42
24. Van Leuven F, Stas L, Hillicker C, et al. Molecular cloning and characterization of the human interleukin-11 receptor α-chain gene, IL11 RA, located on chromosome 9p13. Genomics 1996; 31: 65-70
25. Neben TY, Loebelenz J, Hayes L, et al. Recombinant human interleukin-11 stimulates megakaryocytopoiesis and increases peripheral platelets in normal and splenectomized mice. Blood 1993; 81: 901-8
26. Schlerman FJ, Bree AG, Kaviani MD, et al. Thrombopoietic activity of recombinant human interleukin 11 (rhIL-11) in normal and myelosuppressed nonhuman primates. Stem Cells 1996 14: 517-32
27. Kaviani MD, Mason LE, Nagle SL, et al. Effects of subcutaneously administered recombinant human interleukin-11 on platelet reactivity and ultrastructure in nonhuman primates [abstract]. Blood 1996; 88 (10 Suppl. 1): 26a
28. Hangoc G, Yin T, Cooper S, et al. In vivo effects of recombinant interleukin-11 on myelopoiesis in mice. Blood 1993; 81: 965-72
29. Leonard JP, Quinto CM, Kozitza MK, et al. Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin. Blood 1994; 83: 1499-506
30. Maze R, Moritz T, Williams DA. Increased survival and multilineage hematopoietic production from delayed and severe myelosuppressive effects of a nitrosourea with recombinant interleukin-11 (IL-11). Cancer Res 1994; 54: 4947-51
31. Du XX, Neben TY, Goldman SJ, et al. Effects of recombinant human interleukin 11 on hematopoietic reconstitution in transplant mice: acceleration of recovery of peripheral blood neutrophils and platelets. Blood 1993; 81: 27-34
32. Paul SR, Hayes LL, Palmer R, et al. Interleukin-11 expression in donor bone marrow cells improves hematological reconstitution in lethally irradiated mice. Exp Hematol 1994; 22: 295-301
33. Hawley RG, Hawley TS, Fong AZ, et al. Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin-11. Proc Natl Acad Sci USA 1996; 93: 10297-302
34. Gordon MS, McCaskill-Stevens WJ, Battiato LA, et al. A phase I trial of recombinant human interleukin-11 (Neumega®, rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 1996; 87: 3615-24
35. Tepler I, Elias L, Smith II JW, et al. A randomized placebo-controlled trial of recombinant human interleukin-11 in cancer patients with severe thrombocytopenia due to chemotherapy. Blood 1996; 87: 3607-14
36. Du XX, Doerschuk CM, Williams DA. A bone marrow stromal-derived growth factor, interleukin-11, stimulates recovery of small intestinal mucosal cells after cytoablative therapy. Blood 1994; 83: 33-7
37. Orazi A, Du XX, Yang Z, et al. Interleukin-11 prevents apoptosis and accelerates recovery of small intestinal mucosa in mice treated with combined chemotherapy and radiation. Lab Invest 1996 75: 33-42
38. Sonis ST, Muska A, O'Brien JO, et al. Alteration in the frequency, severity and duration of chemotherapy-induced mucositis in hamsters by interleukin-11. Eur J Cancer B Oral Oncol 1995; 31B: 261-6
39. Sonis ST, Dotoli EA, Muska AD, et al. Effect of topical and subcutaneous administration of interleukin-11 on chemotherapy-induced ulcerative mucositis in hamsters [abstract]. Proc Am Assoc Cancer Res 1995 Mar; 36: A2190
40. Potten CS. Interleukin-11 protects the clonogenic stem cells in murine small intestinal crypts from impairment of their reproductive capacity by radiation. Int J Cancer 1995; 62: 356-61
41. Peterson RL, Bozza MM, Dorner AJ. Interleukin-11 induces intestinal epithelial cell growth arrest through effects on retinoblastoma protein phosphorylation. Am J Pathol 1996; 149: 895-902
42. Booth C Potten CS. Effects of IL-11 on the growth of intestinal epithelial cells in vitro. Cell Prolif 1995; 28: 581-94
43. Paglia D, Oran A, Lu C, et al. Expression of leukemia inhibitory factor and interleukin-11 by human melanoma cell lines: LIE, IL-6, and IL-11 are not coregulated. J Interferon Cytokine Res 1995; 15: 455-60
44. Teicher BA, Chen YN, Ara G, et al. Interaction of interleukin-11 with cytotoxic therapies in vitro against CEM cells and in vivo against EMT-6 murine mammary carcinoma. Int J Cancer 1996; 67(6): 864-70
45. Hammer RE, Maika SD, Richardson JA, et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112
46. Keith JC, Albert A, Sonis ST, et al. IL-11 a pleiotropic cytokine: exciting new effects of IL-11 on gastrointestinal mucosal biology. Stem Cells 1994; 12 Suppl. 1: 79-90
47. Keith Jr JC, Albert LM, Ferranti TJ, et al. Recombinant human interleukin-11 (rhIL-11) decreases inflammatory bowel disease in HLA-B27 transgenic rats [abstract]. Gastroenterology 1995; 108 Suppl. 4: A317
48. Albert LM, Ferranti TJ, Erickson JE, et al. Dose response and schedule studies of recombinant human interleukin-11 in acetic acid-induced colonic injury in rats [abstract]. Gastroenterology 1995; 108 Suppl. 4: A316
49. Qiu B, Pfeiffer CJ, Keith Jr JC. Protection by recombinant human interleukin-11 against experimental TNB-induced colitis in rats. Dig Dis Sci 1996; 41(8): 1625-30
50. Castagliuolo I, Kelly CP, Qui BS, et al. IL-11 inhibits Clostridium difficile toxin A enterotoxicity in rat ileum. Am J Physiol 1997; 273: G333-41
51. Redlich CA, Gao X, Rockwell S, et al. IL-11 enhances survival and decreases TNF production after radiation-induced thoracic injury. J Immunol 1996; 157: 1705-10
52. Opal SM, Keith Jr JC. Potential role for human interleukin-11 in bacterial sepsis. In: Vincent J-L, editor. Yearbook of intensive care and emergency medicine. Berlin: Springer Verlag, 1996: 111-8
53. Barton BE, Shortall J, Jackson JV. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect Immun 1996; 64: 714-8
54. Misra BR, Ferranti TJ, Keith Jr JC, et al. Recombinant human interleukin-11 prevents hypotension in LPS-treated anesthetized rabbits. J Endotoxin Res 1996 3 (4): 297-305
55. Morgan GW, Breit SN. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Rad Oncol Biol Phys 1995; 31: 361-9
56. Baumann H, Schendel P. Interleukin-11 regulates the hepatic-expression of the same plasma protein genes as interleukin-6. J Biol Chem 1991; 266: 20424-7
57. Fukuda Y, Sassa S. Effect of interleukin-11 on the levels of mRNAs encoding heme oxygenase and haptoglobin in human HepG2 hepatoma cells. Biochem Biophys Res Commun 1993; 193: 297-302
58. Willis D, Moore AR, Frederick R, et al. Heme oxygenase: a novel target for the modulation of the inflammatory response. Nature Med 1996; 2: 87-90
59. Roeh E, Graeve L, Hoffman R, et al. Regulation of tissue inhibitor of metalloproteinases-1 gene expression by cytokines and dexamethasone in rat hepatocyte primary cultures. Hepatology 1993; 18: 1437-42
60. Kaye JA, Loewy J, Blume J, et al. Recombinant human interleukin eleven (Neumega™, rhIL-11 growth factor) increases plasma von Willebrand factor and fibrinogen concentrations in normal human subjects [abstract]. Blood 1994; 84 (10 Suppl. 1): 276a
61. Ault K, Mitchell J, Knowles C, et al. Recombinant human interleukin eleven (Neumega™, rhIL-11 growth factor) increases plasma volume and decreases sodium excretion in normal human subjects [abstract]. Blood 1994; 84 (10 Suppl. 1): 276a
62. Keith Jr JC, Badalone V, Schaub RG. Concurrent Lasix administration with recombinant human interleukin-11 (rhIL-11) attenuates plasma volume expansion in dogs [abstract]. Blood 1995; 86(10 suppl. 1): 997a
63. Dykstra K, Rogge H, Stone A, et al. Effect of diuretic treatment on rhIL-11-induced salt and water retention [abstract]. Blood 1996; 88 (10 Suppl. 1): 346a
64. Bank S, Sninsky C, Robinson M, et al. Safety and activity evaluation of rhIL-11 in subjects with active Crohn's disease [abstract]. Gastroenterology 1997; 112 (4 Suppl. 1): A927